Steward Financial Group’s Arcus Biosciences RCUS Stock Holding History

Steward Financial Group’s Portfolio RCUS Stock Details RCUS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$0	Buy	+24	New	+$482	﹤0.01%	1519
2023 Q2	–	Sell	-13	Closed	–	–	883
2023 Q1	$0	Hold	13	–	–	﹤0.01%	878
2022 Q4	$0	Buy	+13	New	+$358	﹤0.01%	764
2022 Q3	–	Sell	-13	Closed	–	–	1037
2022 Q2	$0	Buy	+13	New	+$318	﹤0.01%	1299

Other funds holding RCUS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

OCA

Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return

IFA

Invus Financial Advisors New York $89.2M AUM 10.79% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Steward Financial Group's RCUS Position: Q3 2023 in Review

Steward Financial Group opened a new position in Arcus Biosciences (RCUS) in Q3 2023: 24 shares worth $0. The stake represents ﹤0.01% of the portfolio and ranks #1519 among its holdings. This is a return to the name: Steward Financial Group previously reported a position in RCUS as recently as Q1 2023.

Steward Financial Group first reported a position in RCUS in Q2 2022 and has held it in 4 quarters since. 187 funds tracked by Wall St. Rank hold RCUS as of Q3 2023.

Steward Financial Group held 24 shares of Arcus Biosciences worth $0 as of Q3 2023.
Arcus Biosciences was a new Steward Financial Group position in Q3 2023.
Arcus Biosciences made up ﹤0.01% of Steward Financial Group's portfolio in Q3 2023, its #1519 holding.
Steward Financial Group first reported a position in Arcus Biosciences in Q2 2022 and has held it in 4 quarters since.
187 funds tracked by Wall St. Rank held Arcus Biosciences as of Q3 2023.

Based on Steward Financial Group's 13F filing for Q3 2023, filed 23 Oct 2023.